Open AccessEffects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study
Author(s) -
Thomas Wilke,
Burkhard Weisser,
HansGeorg Predel,
Roland E. Schmieder,
Sven Waßmann,
Anton Gillessen,
Jörg Blettenberg,
Ulf Maywald,
O. Randerath,
Sabrina Müller,
Michael Böhm
Publication year - 2022
Publication title -
integrated blood pressure control
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.652
H-Index - 20
ISSN - 1178-7104
DOI - 10.2147/ibpc.s336324
Subject(s) - medicine , amlodipine , ramipril , valsartan , hydrochlorothiazide , pill , dyslipidemia , hazard ratio , candesartan , pharmacology , angiotensin ii , blood pressure , confidence interval , obesity
Current guidelines for the treatment of arterial hypertension (AH) or cardiovascular (CV) prevention recommend combination drug treatments with single pill combinations (SPC) to improve adherence to treatment. We aimed to assess whether the SPC concept is clinically superior to multi pill combination (MPC) with identical drugs.